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ABSTRACT
Pseudomonas aeruginosa spp are the most prevalent bacteria that cause nosocomial
infections in hospitals. Most antibiotics, including novel new β-lactams, are already resistant
to them, and they can become resistant during treatment, which can make the treatment fail.
P. aeruginosa isolates from ICU patients who had Per-1 and VEB-1 were the main focus of
this study. These two ESBLs are the two most common in ICU patients who had them. 50
isolates were gathered from Peshawar's LRH ICU facilities in the year 2021. The antibiotic
susceptibility test was conducted in accordance with the Clinical and Laboratory Standards
Institute's standards (CLSI). The combination disc test used to identify isolates that produce
ESBLs. Ceftazidime MIC was determined using the agar dilution method using particular
primers, the PER-1 and VEB-1 genes were detected using polymerase chain reaction (PCR).
Fifty-six percent patients (n=40) male, whereas forty percent (n=25) were female.
Augmentin (96.6%, n=61) and cefpodoxim (86.7%, n=55) resistance was found in the
majority of ICU isolates. Fifty isolates (77%) tested positive for ESBL, with 94 percent
(n=47) carrying the PER-1 gene and VEB-1 gene 52 percent (n=26). Ten isolates had
blaPER1 and blaVEB1 present at the same time, and seven of them amplified all three
genes. ESBL producers were found in a large number of ICU P. aeruginosa isolates.
Although blaVEB1 and blaPER1 were found in a small number of isolates, their frequency
was very high. Furthermore, carbapenem resistance was negligible. Because of drugresistant P. aeruginosa isolates, it is vital to monitor ICU centers.
Keywords: blaPER1, blaVEB1, P. aeruginosa isolates, P. aeruginosa. ESBL producer.
INTRODUCTION
Although produced infrequently,
the acquired beta-lactamase enzymes
blaPER-1 and blaVEB-1 are clinically

important because they confer resistance
to oxyimino beta-lactams (Kumar et al.
2012). Due to its wide spectrum of
activity against gram-positive and gramnegative isolates, carbapenem resistance
is also a severe concern (Ghasemian et al.
140
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2018).
Carbapenem resistance is
common in Pseudomonas aeruginosa as
well as Klebsiella pneumoniae and
Acinetobacter spp. The goal of the study
is to find the genes that make the Class A
ESBLs blaPER-1 and blaVEB-1 in P.
aeruginosa clinical isolates from ICU
patients (Nojoomi et al., 2016).
Pseudomonas aeruginosa is a common
cause of infections in hospitals, such as
pneumonia, burn infections, urinary tract
infections, meningitis, and bacteremia
(Kohlenberg et al., 2010). In immunecompromised patients, infections can
quickly escalate to a dangerous level. In
people who don't have a strong immune
system, infections can quickly get out of
hand and become dangerous (Fernandes
et al., 2013).
Antibiotics have been widely used
for many years, but resistance genes have
only lately emerged and become
widespread (Saderi et al., 2008).
Extended-spectrum-lactamases
cause
resistance
to
broad-spectrum
cephalosporins such as cefotaxime,
ceftriaxone, ceftazidime, and aztreonam
(ESBLs). It used to be known that
Klebsiella pneumoniae and Escherichia
coli had some of these enzymes, but now
they have been found in other pathogens
as well. Carbapenem antibiotics have
become more common, which has led to
more carbapenem-resistant P. aeruginosa
clinical isolates that are hard to treat. This
has cut down on the treatment options for
this disease (Saleh et al., 2016). Between
the years 2021 and 2022, 50 samples of
P. aeruginosa isolates from intensive care
unit (ICU) patients of LRH hospitals in
Peshawar, and the results were published
in the journal mBio. It was done with
hydrogen sulphide (H2S) tests, indole
tests, catalase and oxidase tests, motility
tests, triple sugar iron agar, urease, and
Macconkey agar tests (Gupta et al.,
2010).

MATERIALS AND METHODS
Bacterial Isolates
Between 2021 and 2022, 50
samples of P. aeruginosa obtained from
patients admitted to (ICUs) at LRH
hospitals in Peshawar. All of the strains
of bacteria were identified using
hydrogen sulphide (H2S) tests, indole,
motility, triple-sugar iron agar (TSI)
catalase and oxidase tests, urease, and
Macconkey agar (Tavajjohi et al., 2011).
Antibiotic Susceptibility Test
It was done in accordance with
CLSI guidelines when the antibiotic
susceptibility test was done, Antibiotics
that were used: Levofloxacin (5µg),
gentamycin (100 µg), cefepime (25µg),
cepodoxime
(15µg),
ciprofloxacin
(10µg), tobramycin (10µg), ofloxcine
(5µg), cefepime (25µg), amikacin (30µg),
augmentin (25µg), tetracycline (50µg),
ceftriaxone (30µg) (Tavajjohi et al.,
2011).
Phenotypic
Producers

Detection

of

ESBL

The isolates that developed
ESBLs were found using the combine
disc test. We tested the efficacy of two
different antibiotics, ceftazidime and
cefotaxime discs, one with and one
without clavulanic acid and Clampulanic
acid was added, and when it was, a disc
separation of more than 5 mm was seen
as good (Hosseini et al., 2007).
DNA Extraction
Polymerase chain reaction using
specific primers was used to identify the
VEB-1, PER-1 and encoding genes
(Table 1).
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Table 1: Primers used in this study
Primer

Sequence 3' to 5'

Product size

Reference

blaPER-1

F: ATA GGA CTG TTA ATA TTT TCG

634

1,12

925

9,12

R: ATT ATC GGT TCG GAT CG
blaVEB-1

F: AGC TTC ACC TAT CGC GTT GC
R: GCA CAC TAC AGC GGA TGC TC

The reaction combination for
these genes as follows: 10XPCR buffer
equals 2.5 L, MgCl2 (50 mM) equals 1.5
L, dNTP (10 Mm) equals 0.75 L, forward
primer (100 M) equals 2.5 L, reverse
primer (100 M) equals 2.5 L, Taq DNA
polymerase (5 U/l) equals 0.2 L, template
(DNA) equals 1 L, and nuclease-free
H2O equals 14.05 L.10XPCR buffer
equals 2.5 L (Szabó et al., 2008).
Figure 1: Bla PER1 gene with 634 bp size.

Polymerase Chain Reaction (PCR)
Antibiotic Susceptibility Test
Polymerase chain reaction (PCR)
was used to look for the PER-1, VEB-1,
and genes that make them with specific
primers (Table 1). 10XPCR buffer: 2.5
mL; MgCl2: 1.5 mL; DNTPs: 10 mL;
Forward and reverse primers: 2.5 mL
each; Taq DNA polymerase: 0.25 U/mL;
0.2 mL; and H2O: 14.05 mL (Spagnolo et
al., 2014).
Data Analysis

The overall isolates (96.8 percent,
n=62) and cefpodoxime (86.7 percent,
n=57) resistant to Augmentin. CAZ (65
percent, n=40), CPM (48.6 percent,
n=30), AMP (47.6, n=28), CEP (66.6
percent, n=41), AMC (59 percent, n=38)
CTX (68.4 percent, n=38), CIP (46.07
percent, n=29), OFX (36.2 percent,
n=18), LEV (59.3 percent, n=31), GEN
(36.9 percent, n=24) (Fooladi et al.,
2016).

SPSS 20 was used to analyses the
data t-test was used, and P value of < 0.05
was used to determine the significance of
the result.
RESULTS
Results indicate that 46.1 percent
(n = 30) of the 50 isolates were found in
urine, 15.9 percent (n = 11) in
pneumonia, and 10.8 percent (n = 10) in
blood and other locations. Most of the
patients were male, with 56% (n = 39)
and 44% (n = 25) of them.

Figure 2: Bla VEB1 gene with 925 bp size.
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Phenotypically
producers

detection

of

ESBL

P. aeruginosa isolates were ESBL
positive in 50 (75%) of the cases. Urine
infection (63 percent, n=40), wound (25
percent, n=16), sputum was (16.2 percent,
n=11) were the most common ESBL
positive isolates (Davodian et al., 2015).
Detection of PER-1
encoding genes

VEB-1

and

Fifty isolates (75%) tested
positive for ESBL, with 92 percent
(n=48) carrying the blaPER-1 gene and
52 percent (n=26) carrying the blaVEB-1
gene (Figures 1 and 2). Ten isolates had
blaPER-1 and blaVEB1 present at the
same time, and seven of them amplified
all three genes. Resistance showed toward
ceftriaxone, ceftazidime, and cefotaxime
was linked to the presence of these genes
(Yusuf et al., 2017).
DISCUSSION
Pseudomonas aeruginosa spp is a
common bacterium responsible for a
broad spectrum of nosocomial infection.
Antibiotic resistance P. aeruginosa
isolates is a result of a combination of
innate and acquired (chromosome or
plasmid-mediated) mechanisms. Majority
of the P.aeruginosa isolates in our
investigation came from infections of the
urinary tract. Our findings are backed up
by a number of earlier investigations
(Shacheraghi et al., 2010). Because the
principal route of antibiotic excretion
from the body is through the urine, the
bulk of the resistant isolates were
discovered there. Many tested isolates
were noticed to resistant augmentin, and
cefotaxime and also third-generation
cephalosporins. It is a big concern that
antibiotic resistance is on the rise in
gram-negative rods. P. aeruginosa has a
small number of antibiotic resistance
genes (approximately 0.3 percent of the
total number of genes in the organism).

ESBL producers made up about 77
percent of ICU isolates, which is similar
to prior investigations. The presence of
Amp C
resistance to clavulanic acid
suggests the presence of maybe additional
gene that are unaffected by this inhibitor.
CONCLUSION
To the best of our knowledge, this
is the first study in Peshawar, Pakistan, to
detect metallo-β-lactamase genes in
Pseudomonas aeruginosa isolates. A high
number isolates of P. aeruginosa from
ICU were ESBL producer’s mechanism
(Davodian et al., 2016). The frequency of
blaVEB1 and blaPER1 were relatively
high, while blaPSE1 was detected among
a low number of isolates. ICU wards are
of main sources for infections with drugresistant
strains.
Continuous
and
prolonged
antibiotic
periods,
hospitalization and misuse are pivotal
factors in the selection of highly resistant
strains. Combination therapy (usually
with a β-lactam and an aminoglycoside)
is important to treat Pseudomonas
infections.
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